5,060 reports of this reaction
2.1% of all PSEUDOEPHEDRINE HCL reports
#4 most reported adverse reaction
PEMPHIGUS is the #4 most commonly reported adverse reaction for PSEUDOEPHEDRINE HCL, manufactured by Major Pharmaceuticals. There are 5,060 FDA adverse event reports linking PSEUDOEPHEDRINE HCL to PEMPHIGUS. This represents approximately 2.1% of all 242,486 adverse event reports for this drug.
Patients taking PSEUDOEPHEDRINE HCL who experience pemphigus should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PEMPHIGUS is a less commonly reported adverse event for PSEUDOEPHEDRINE HCL, but still significant enough to appear in the safety profile.
In addition to pemphigus, the following adverse reactions have been reported for PSEUDOEPHEDRINE HCL:
The following drugs have also been linked to pemphigus in FDA adverse event reports:
PEMPHIGUS has been reported as an adverse event in 5,060 FDA reports for PSEUDOEPHEDRINE HCL. This does not prove causation, but indicates an association observed in post-market surveillance data.
PEMPHIGUS accounts for approximately 2.1% of all adverse event reports for PSEUDOEPHEDRINE HCL, making it a notable side effect.
If you experience pemphigus while taking PSEUDOEPHEDRINE HCL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.